Bo Kruse - 04 Jan 2022 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
EVP, CFO, Secretary & Treas.
Signature
/s/ Bo Kruse
Issuer symbol
YMAB
Transactions as of
04 Jan 2022
Net transactions value
-$68,480
Form type
4
Filing time
05 Jan 2022, 16:15:50 UTC
Previous filing
23 Dec 2021
Next filing
25 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Sale $68,480 -4,000 -2% $17.12 193,077 04 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2021.